Pharmica Consulting has joined ProPharma Group.

Effective February 1, 2022, this site will no longer be accessible, and you will automatically be directed to our regulatory, clinical, and compliance services supporting clients throughout the full product lifecycle. Learn about our expanded services.

Inside Investigator Meetings (Part 1 – The Good)

Nowadays, conducting a clinical study is more complicated than ever. Clinical studies have more complex protocols, new technologies, and increased regulatory scrutiny. It has made study execution more challenging. Regardless of the rise in difficulty, what matters is that a sponsor collects good, clean data that reflect how well its drug works. This increased difficulty raises[…]